New York, NY -- (SBWIRE) -- 01/06/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: ZIOPHARM Oncology Inc (NASDAQ:ZIOP), Genco Shipping & Trading Limited (NYSE:GNK), Avanir Pharmaceuticals Inc (NASDAQ:AVNR), American Apparel Inc (NYSEMKT:APP)
ZIOPHARM Oncology Inc (NASDAQ:ZIOP) showed a volume of 1.32 million shares by the end of last trade whereas the average volume of the stock remained 1.20 million shares. The stock opened the session at $4.18 but then moved to $4.37. At that price, the stock showed a positive performance of 4.05%. ZIOPHARM Oncology, Inc., is a biotechnology company. The Company employs gene expression and control technology to deliver deoxyribonucleic acid (DNA) for the treatment of cancer. The Company's technology employs Intrexon Corporation's RheoSwitch Therapeutic System to turn on and off, and precisely modulate, gene expression at the cancer site in order to improve the therapeutic index.
Will ZIOP Continue To Move Higher? Find Out Here
Genco Shipping & Trading Limited (NYSE:GNK) opened the session at $2.57 and closed the session at 2.43. The stock showed a negative performance of -5.08% in previous trading session. Traded with volume of 1.31 million shares in the prior session and the average volume of the stock remained 2.02 million shares. Genco Shipping & Trading Limited (GS&T) transports iron ore, coal, grain, steel products and other drybulk cargoes along worldwide shipping routes through the ownership and operation of drybulk carrier vessels. As of December 31, 2012, GS&T’s fleet consisted of 53 drybulk carriers, including nine capesize, eight panamax, 17 supramax, six handymax and 13 handysize drybulk carriers,
Has GNK Found The Bottom And Ready To Gain Momentum? Find Out Here
Avanir Pharmaceuticals Inc (NASDAQ:AVNR) opened the session at $3.21 and closed the session at $3.31. The stock showed a positive performance of 3.12% in previous trading session. Traded with volume of 1.31 million shares in the prior session and the average volume of the stock remained 3.06 million shares. The beta of the stock remained 1.36. AVANIR Pharmaceuticals, Inc. (AVANIR) is a pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of central nervous system disorders. The Company focuses on products for the central nervous system. It also has a number of partnered programs in other therapeutic areas. Its docosanol 10% cream, sold in the United States and Canada as Abreva by its marketing partner GlaxoSmithKline Consumer Healthcare,
Why Should Investors Buy AVNR After The Recent Gain? Just Go Here and Find Out
American Apparel Inc (NYSEMKT:APP) the stock advanced 6.72% and finished the session at $1.27. Traded with volume of 1.31 million shares in the prior session and the average volume of the stock remained 645,074.00 shares. The beta of the stock remained 3.15. American Apparel, Inc. is a vertically integrated manufacturer, distributor, and retailer of branded fashions basic apparel and accessories for women, men, children and babies. As of January 31, 2013, the Company had operated 251 retail stores in 20 countries. The Company operates in four business segment: U.S. Wholesale, U.S. Retail, Canada, and International.
Will APP Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)